IBDEI1LZ ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27291,1,4,0)
 ;;=4^T82.898D
 ;;^UTILITY(U,$J,358.3,27291,2)
 ;;=^5054954
 ;;^UTILITY(U,$J,358.3,27292,0)
 ;;=N25.81^^106^1346^36
 ;;^UTILITY(U,$J,358.3,27292,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27292,1,3,0)
 ;;=3^Secondary Hyperparathyroidism of Renal Origin
 ;;^UTILITY(U,$J,358.3,27292,1,4,0)
 ;;=4^N25.81
 ;;^UTILITY(U,$J,358.3,27292,2)
 ;;=^5015617
 ;;^UTILITY(U,$J,358.3,27293,0)
 ;;=T82.858A^^106^1346^37
 ;;^UTILITY(U,$J,358.3,27293,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27293,1,3,0)
 ;;=3^Stenosis of Vascular Graft,Init Encntr
 ;;^UTILITY(U,$J,358.3,27293,1,4,0)
 ;;=4^T82.858A
 ;;^UTILITY(U,$J,358.3,27293,2)
 ;;=^5054941
 ;;^UTILITY(U,$J,358.3,27294,0)
 ;;=T82.858D^^106^1346^38
 ;;^UTILITY(U,$J,358.3,27294,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27294,1,3,0)
 ;;=3^Stenosis of Vascular Graft,Subs Encntr
 ;;^UTILITY(U,$J,358.3,27294,1,4,0)
 ;;=4^T82.858D
 ;;^UTILITY(U,$J,358.3,27294,2)
 ;;=^5054942
 ;;^UTILITY(U,$J,358.3,27295,0)
 ;;=T82.868A^^106^1346^39
 ;;^UTILITY(U,$J,358.3,27295,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27295,1,3,0)
 ;;=3^Thrombosis of Vascular Graft,Init Encntr
 ;;^UTILITY(U,$J,358.3,27295,1,4,0)
 ;;=4^T82.868A
 ;;^UTILITY(U,$J,358.3,27295,2)
 ;;=^5054947
 ;;^UTILITY(U,$J,358.3,27296,0)
 ;;=T82.868D^^106^1346^40
 ;;^UTILITY(U,$J,358.3,27296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27296,1,3,0)
 ;;=3^Thrombosis of Vascular Graft,Subs Encntr
 ;;^UTILITY(U,$J,358.3,27296,1,4,0)
 ;;=4^T82.868D
 ;;^UTILITY(U,$J,358.3,27296,2)
 ;;=^5054948
 ;;^UTILITY(U,$J,358.3,27297,0)
 ;;=N28.1^^106^1347^1
 ;;^UTILITY(U,$J,358.3,27297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27297,1,3,0)
 ;;=3^Cyst of Kidney,Acquired
 ;;^UTILITY(U,$J,358.3,27297,1,4,0)
 ;;=4^N28.1
 ;;^UTILITY(U,$J,358.3,27297,2)
 ;;=^270380
 ;;^UTILITY(U,$J,358.3,27298,0)
 ;;=Q61.9^^106^1347^2
 ;;^UTILITY(U,$J,358.3,27298,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27298,1,3,0)
 ;;=3^Cystic Kidney Disease,Unspec
 ;;^UTILITY(U,$J,358.3,27298,1,4,0)
 ;;=4^Q61.9
 ;;^UTILITY(U,$J,358.3,27298,2)
 ;;=^5018800
 ;;^UTILITY(U,$J,358.3,27299,0)
 ;;=Q61.2^^106^1347^6
 ;;^UTILITY(U,$J,358.3,27299,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27299,1,3,0)
 ;;=3^Polycystic Kidney,Adult Type
 ;;^UTILITY(U,$J,358.3,27299,1,4,0)
 ;;=4^Q61.2
 ;;^UTILITY(U,$J,358.3,27299,2)
 ;;=^5018796
 ;;^UTILITY(U,$J,358.3,27300,0)
 ;;=Q61.5^^106^1347^4
 ;;^UTILITY(U,$J,358.3,27300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27300,1,3,0)
 ;;=3^Medullary Cystic Kidney
 ;;^UTILITY(U,$J,358.3,27300,1,4,0)
 ;;=4^Q61.5
 ;;^UTILITY(U,$J,358.3,27300,2)
 ;;=^67073
 ;;^UTILITY(U,$J,358.3,27301,0)
 ;;=Z82.71^^106^1347^3
 ;;^UTILITY(U,$J,358.3,27301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27301,1,3,0)
 ;;=3^Family Hx of Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,27301,1,4,0)
 ;;=4^Z82.71
 ;;^UTILITY(U,$J,358.3,27301,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,27302,0)
 ;;=Q61.5^^106^1347^5
 ;;^UTILITY(U,$J,358.3,27302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27302,1,3,0)
 ;;=3^Medullary Sponge Kidney
 ;;^UTILITY(U,$J,358.3,27302,1,4,0)
 ;;=4^Q61.5
 ;;^UTILITY(U,$J,358.3,27302,2)
 ;;=^67073
 ;;^UTILITY(U,$J,358.3,27303,0)
 ;;=Q61.3^^106^1347^7
 ;;^UTILITY(U,$J,358.3,27303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27303,1,3,0)
 ;;=3^Polycystic Kidney,Unspec
 ;;^UTILITY(U,$J,358.3,27303,1,4,0)
 ;;=4^Q61.3
 ;;^UTILITY(U,$J,358.3,27303,2)
 ;;=^5018797
 ;;^UTILITY(U,$J,358.3,27304,0)
 ;;=E11.65^^106^1348^11
 ;;^UTILITY(U,$J,358.3,27304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27304,1,3,0)
 ;;=3^Diabetes Type 2 w/ Hyperglycemia
